New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
April 14, 2015
09:26 EDTJPMJPMorgan core EPS beat expectations, says Wells Fargo
Subscribe for More Information
09:13 EDTJPMOn The Fly: Pre-market Movers.
UP AFTER EARNINGS: JPMorgan Chase (JPM), up 1%... Johnson & Johnson (JNJ), up marginally... Triangle Petroleum (TPLM), up 4.2%... Fastenal (FAST), up 5%. ALSO HIGHER: Brainstorm Cell Therapeutics (BCLI), up 13.5% after announcing that it will present NurOwn Phase 2a clinical data at the Academy of Neurology annual meeting... Builders FirstSource (BLDR), up 7.2% after being upgraded to Buy from Hold at Stifel... Solazyme (SZYM), up 7.5% after announcing a strategic agreement with Flotek (FTK)... Cleveland BioLabs (CBLI), up 6.8% after receiving funding recommendation from the Department of Defense... Nordic American Tanker (NAT), up 3.2% after raising quarterly dividend to 38c from 22c... Ocwen (OCN), up 3.8% after reporting preliminary fiscal 2014 results. DOWN AFTER EARNINGS: Wells Fargo (WFC), down just under 1%. ALSO LOWER: Norfolk Southern (NSC), down 5.8% after being downgraded to Hold from Buy at TD Securities... RXi Pharmaceuticals (RXII), down 14.3% after filing to sell $20M of common stock and warrants... Arrowhead Research (ARWR), down 4.5% after being downgraded to Hold from Buy at Jefferies.
09:08 EDTJPMJPMorgan says reasonable to expect 'modest' further reserve builds due to E&P
Subscribe for More Information
08:49 EDTJPMJPMorgan says business simplification to have overall neutral impact to Q2 P&L
Subscribe for More Information
08:40 EDTAAPLSeveral signs suggest Apple may build a car, says Bernstein
Subscribe for More Information
07:22 EDTJPMJPMorgan sees Q2 Markets revenue hurt $300M by business simplification
Subscribe for More Information
07:20 EDTJPMJPMorgan sees FY15 core loan growth of 10%+/-
Subscribe for More Information
07:17 EDTJPMJPMorgan reports firmwide total credit reserves of $14.7B
Subscribe for More Information
07:10 EDTJPMJPMorgan up 0.5% to $62.35 in pre-market following Q1 report
Subscribe for More Information
07:08 EDTJPMJPMorgan reports Q1 Basel III common equity Tier 1 ratio 10.6%
Subscribe for More Information
07:06 EDTJPMJPMorgan CEO says franchise getting safer, stronger
Jamie Dimon, JPMorgan Chairman and CEO, said: “JPMorgan Chase continues to support consumers, businesses and communities and make a significant positive impact. We have an outstanding franchise which is getting safer and stronger, and is gaining market share over time. We continue to build the company for the long-term, we are investing in controls, infrastructure, systems, technology, new products and bankers. We will continue to navigate challenges and deliver for our clients, shareholders and communities.”
07:03 EDTJPMJPMorgan reports tangible book value per share up 9% to $45.45
Subscribe for More Information
07:01 EDTJPMJPMorgan says Q1 results include $487M, or 13c, significant item legal expense
Subscribe for More Information
07:00 EDTJPMJPMorgan reports Q1 EPS $1.45, consensus $1.40
Reports Q1 GAAP revenue $24.1B, consensus $24.5B. Reports Q1 managed basis revenue $24.82B.
06:25 EDTWDCWestern Digital upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded Western Digital to Buy and maintained its $117 price target. The firm believes fundamentals have bottomed and valuation is attractive at current levels. BofA/Merrill lowered estimates on further PC weakness but said pricing is holding up and the mix shift to capacity HDDs is driving ASP and margin improvement.
05:48 EDTAAPLReport: Foxconn engaged in selling second-hand iPhones in China, DigiTimes says
Subscribe for More Information
April 13, 2015
17:10 EDTAAPLIBM establishes a Watson Health Cloud
Subscribe for More Information
16:51 EDTNVSDiplomat Pharmacy to dispense Novartis' JADENU
Diplomat Pharmacy is set to distribute JADENU, a drug recently approved by the U.S. FDA to treat patients with chronic iron overload. JADENU is a new oral formulation of EXJADE for the treatment of chronic iron overload due to blood transfusions in patients age 2 and older, and chronic iron due to NTDT in patients age 10 and older.
16:21 EDTJPM, AAPLOn The Fly: Top stock stories for Monday
Subscribe for More Information
16:01 EDTAAPLOptions Update; April 13, 2015
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use